effects of metabolic syndrome of pain and physical function in knee pai
Not Applicable
- Conditions
- Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects diagnosed with knee osteoarthritis
Patient Aged range between 40 to 70
Both genders included
Subjects were required to be able to
understand the questions and be able to communicate
Exclusion Criteria
Patient with inflammatory joint disease
trauma induced arthritis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Knee Injury and Osteoarthritis Outcome Score (KOOS)Timepoint: baseline
- Secondary Outcome Measures
Name Time Method umerical Rating Scale (NRS)Timepoint: 4 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link metabolic syndrome to knee OA pain and physical dysfunction in CTRI/2024/03/064140?
How does metabolic syndrome management affect knee OA outcomes compared to standard care in CTRI/2024/03/064140?
Which biomarkers predict response to metabolic syndrome interventions in knee OA patients (CTRI/2024/03/064140)?
What adverse events are associated with metabolic syndrome in knee OA patients (CTRI/2024/03/064140) undergoing treatment?
What role do GLP-1 agonists or SGLT2 inhibitors play in knee OA with metabolic syndrome (CTRI/2024/03/064140)?